RecruitingPhase 3ACTRN12605000489695
A prospective double blind randomised clinical trial of 70% ethanol to treat proven or suspected catheter related sepsis in haematology patients.
Sponsor
Dr Alan Pithie
Enrollment
20 participants
Start Date
Apr 1, 2002
Study Type
Interventional
Conditions
Eligibility
Sex: Both males and femalesMin Age: 18 Yearss
Inclusion Criteria1
- Proven catheter related sepsis (same organism in both the peripheral blood and central line culture or from the FAS brush). Suspected CRS > 1000 organisms in either FAS sample or Central line blood culture. Consents to participate in the trial Haematological Malignancy Bone Marrow Transplantation.
Exclusion Criteria1
- Known allergy to Ethanol Elevated LFTs (2.5 times above the upper normal range). Known history of Alcoholism. Pregnant of lactating women, Positive cultures both peripherally and centrally but NOT the same organism.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Routine antimircobials with the additon of daily 2 hourly locks of 70% ethanol. This intervention/control will continue until a clinical decision is made to stop the antimircobials.
Routine antimircobials with the additon of daily 2 hourly locks of 70% ethanol. This intervention/control will continue until a clinical decision is made to stop the antimircobials.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12605000489695